Kidney disease can progress quietly for years. A new parliamentary recommendation could put regular kidney checks much earlier on India’s health agenda.
- A parliamentary committee has recommended kidney function testing every six months for everyone aged 20 years and above
- The recommendation also calls for annual chronic kidney disease (CKD) screening among high-risk groups, including people with diabetes and hypertension
- Kidney screening should include eGFR and urine albumin or protein testing, followed by appropriate referral when abnormalities appear
Your kidneys rarely complain when trouble begins, which makes regular testing more important than waiting for symptoms. A person can develop chronic kidney disease while continuing daily life without obvious warning signs (1). By the time symptoms become noticeable, kidney damage may already have progressed considerably. That silent progression is exactly why a new recommendation from an Indian parliamentary committee matters.
The committee has proposed mandatory kidney function tests every six months for adults aged 20 years and above. It has also recommended annual screening for people considered particularly vulnerable to chronic kidney disease.
What has the Parliamentary Panel Recommended for Kidney Testing?
The parliamentary committee has recommended that kidney function testing be carried out every six months for everyone aged 20 years and above. The proposal suggests providing these tests free for people below the poverty line and at nominal cost for others under the National Programme for Prevention and Control of Non-Communicable Diseases. The panel has separately recommended regular annual chronic kidney disease (CKD) screening for people considered high risk.
Importantly, this is a policy recommendation, not a law currently requiring every adult to undergo testing. The proposal is aimed at shifting attention from treating advanced kidney failure toward earlier detection and prevention.
The recommendation comes against the backdrop of a substantial burden of kidney disease in India. According to the report cited by The Week, nearly 2.2 lakh new patients with end-stage kidney disease are added annually. This creates an estimated additional demand of around 3.4 crore dialysis sessions every year (2). These figures highlight the enormous healthcare burden created when kidney disease is detected late.
Who should get Kidney Screening more regularly?
The committee identified several groups that may require particular attention because their risk of chronic kidney disease is higher. People living with diabetes or hypertension are among the most important priority groups identified by the panel. Other groups include adults above 60 years, people with a family history of kidney disease, obesity, or tobacco use. A history of acute kidney injury, recurrent urinary infections, or kidney stones also raises concern.
The panel also highlighted prolonged exposure to medicines that can affect kidney function, including certain non-steroidal anti-inflammatory drugs. This does not mean every person taking these medicines will develop kidney disease. Instead, such factors should prompt a conversation with a healthcare professional about whether kidney monitoring is appropriate. Risk factors can accumulate, making individual assessment more useful than relying on age alone.
Which Tests Check Kidney Function and Kidney Damage?
A kidney check is not simply one blood test that produces a pass or fail result. The committee recommends assessing kidney function through estimated glomerular filtration rate, commonly called eGFR, along with urine albumin or protein testing. eGFR is generally calculated using blood creatinine and provides an estimate of how efficiently the kidneys filter waste. Urine albumin testing can identify protein leakage that may signal kidney damage.
International kidney guidelines similarly emphasize using both eGFR and urine albumin measurements when evaluating chronic kidney disease (3). Kidney Disease Improving Global Outcomes (KDIGO) recommends assessing kidney health using these complementary measures because each provides different information about kidney function and damage (4). The National Kidney Foundation also describes eGFR and urine albumin-to-creatinine ratio as key tests for evaluating kidney health (5). Looking at both results provides a more complete picture than relying on creatinine alone.
Why is Early CKD Detection so Important?
Chronic kidney disease can develop gradually, often without obvious symptoms during its earlier stages. Early identification gives healthcare professionals an opportunity to investigate possible causes and address factors that may accelerate progression. This can include better management of blood pressure, blood sugar, medication use, lifestyle factors, and cardiovascular risks. Finding kidney problems earlier can create more opportunities to slow disease progression.
The parliamentary panel’s recommendation therefore represents a preventive approach rather than simply another routine health check. The idea is to identify people at risk before they require complex interventions such as dialysis. Screening does not mean that every abnormal result automatically represents chronic kidney disease. Persistent abnormalities need appropriate medical assessment and follow-up before a diagnosis is established.
Should Everyone Over 20 Get a Kidney Test Every Six Months?
The proposed six-month testing schedule should not be confused with an established universal medical guideline. It is a recommendation made by the parliamentary committee for consideration within India’s public health system. Current international guidance generally emphasizes risk-based screening and appropriate repeat testing rather than automatically prescribing the same testing interval for every healthy adult. Your personal testing schedule should therefore be decided with your healthcare professional.
For someone with diabetes, hypertension, cardiovascular disease, older age, obesity, family history, or previous kidney problems, regular monitoring may be particularly important. People without recognized risk factors should still discuss preventive screening with their doctor based on age, medical history, medications, and other circumstances. A normal result today does not necessarily eliminate future kidney disease risk.
You do not need to wait for swelling, changes in urination, fatigue, or other symptoms before discussing kidney health. If you have diabetes, high blood pressure, kidney stones, recurrent urinary infections, or a family history, ask whether you need regular screening. A healthcare professional may recommend blood creatinine with eGFR and a urine albumin-to-creatinine ratio based on your individual risk. These relatively simple tests can provide important information before kidney disease becomes advanced.
The proposed policy also sends a larger message about how India approaches chronic disease. Kidney health may need to move from something considered only during serious illness toward something routinely monitored alongside blood pressure, blood sugar, and cholesterol. Whether the six-month recommendation becomes formal policy remains to be seen. For individuals, the most useful step today is knowing your risk and discussing appropriate kidney testing with your doctor.
Frequently Asked Questions
Which doctor should I consult for kidney screening?
You can start with a primary care physician or family doctor, who can assess your risk and refer you to a nephrologist when appropriate.
Is kidney testing every six months mandatory for everyone above 20 in India?
No, the six-month kidney testing plan is a parliamentary committee recommendation and is not currently a universal mandatory requirement.
Which kidney tests should I ask my doctor for?
Ask whether you need a blood creatinine test with eGFR and a urine albumin-to-creatinine ratio based on your risk factors.
Who is at higher risk of chronic kidney disease?
People with diabetes, hypertension, older age, obesity, family history, kidney stones, acute kidney injury, or certain medication exposures have higher risk.
Can kidney disease exist without symptoms?
Yes, chronic kidney disease can remain silent during its earlier stages, which is why screening is important for people at increased risk.
References:
- Overview: Chronic kidney disease
(InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Overview: Chronic kidney disease. [Updated 2024 Sep 11]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK492977/) - Living with dialysis: Activities of daily life, social participation, and quality of life among hemodialysis patients in Chhattisgarh
(Ramasamy S, Galhotra A, Agarwal V, Rathore V. Living with dialysis: Activities of daily life, social participation, and quality of life among hemodialysis patients in Chhattisgarh. J Family Med Prim Care. 2025 Oct;14(10):4362-4369. doi: 10.4103/jfmpc.jfmpc_2113_24. Epub 2025 Oct 31. PMID: 41280598; PMCID: PMC12634001.) - International guidelines for the assessment of chronic kidney disease
(Delanaye P, Jouret F, Cavalier É. Évaluation de la maladie rénale chronique [International guidelines for the assessment of chronic kidney disease]. Rev Med Liege. 2025 May;80(5-6):369-375. French. PMID: 40518892.) - KDIGO 2024 clinical practice guideline on evaluation and management of chronic kidney disease: A primer on what pharmacists need to know
(Awdishu L, Maxson R, Gratt C, Rubenzik T, Battistella M. KDIGO 2024 clinical practice guideline on evaluation and management of chronic kidney disease: A primer on what pharmacists need to know. Am J Health Syst Pharm. 2025 Jun 11;82(12):660-671. doi: 10.1093/ajhp/zxaf044. PMID: 40197825; PMCID: PMC12158546.) - Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review
(Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA. 2015 Feb 24;313(8):837-46. doi: 10.1001/jama.2015.0602. PMID: 25710660; PMCID: PMC4410363.)
Source-Medindia